Business Building

While German pilot projects fail due to regulatory hurdles, Canadian market leader High Tide demonstrates with its Berlin opening how a successful market entry works. Berlin, December 2025 – The contrast could hardly be greater: On one side, addiction experts and the German AIDS Service Organisation present a “showroom” for a cannabis specialty store that […]

The scientific breakthrough that could revolutionize pain therapy In the latest issue of Nature Medicine, a Phase 3 study is causing a stir: VER-01, a standardized full-spectrum cannabis extract, has for the first time in a large-scale clinical trial demonstrated significant success in treating chronic back pain – without signs of addiction or withdrawal. For

An assessment of the proposed tightening of Germany’s Medical Cannabis Law Berlin, July 15, 2025 – The draft bill to amend the Medical Cannabis Act (MedCanG) has been released, and debate is heating up. But amidst all the justified criticism of the current system, we must not lose sight of a key fact: this draft

Great, I’ll gather detailed information on the proposed reprotoxic classification of CBD under review by the European Chemicals Agency (ECHA), with a focus on cosmetic applications—especially CBD flowers in Germany and extracts globally. I’ll also look into UIVEC and CEHTRA’s positions, the implications of the classification on the CBD startup landscape, and what regulatory developments

We’re proud to announce the internal publication of our newest white paper, exclusively available now for our Cannabis-Startups FAMILYMEMBER and readers of this blog. This paper explores a timely and pressing question: How can North American cannabis companies strategically enter the European market—starting with Germany’s groundbreaking Cannabis Act (CanG)? DOWNLOAD HERE Germany: The Entry Point

Many claim that investing in clinical studies is unnecessary because cannabis often lacks protectable intellectual property (IP), studies are very expensive, and success remains uncertain. But now, a German company is proving the opposite! Germany, the land of inventors and thinkers, is once again at the forefront of innovation. Particularly in southern Germany, where hidden

Barcelona is one of the world’s most well-known hotspots for cannabis tourism and home to hundreds of cannabis social clubs. These days, the international cannabis community gathers here, especially during ICBC and Spannabis, the world’s largest cannabis trade fair. While the latest trends, technologies, and business models are discussed at the conference during the day,

The era of unregulated online advertising for medical cannabis seems to be over. With a preliminary injunction, the Hamburg Regional Court (LG) has put the DrAnsay platform and its operator, Can Ansay, in check. The North Rhine Chamber of Pharmacists (AKNR) filed a lawsuit – and won. This marks the beginning of a new phase

On February 27, 2025, two significant rulings were handed down that impact the pharmacy market and digital platform models in Germany. The European Court of Justice (ECJ) and the Federal Court of Justice (BGH) issued key decisions that could also be relevant for cannabis startups. Below, we take a look at these rulings and analyze

The medical cannabis market in Germany is evolving rapidly, and digital transformation is playing a crucial role in shaping its future. As more patients gain access to cannabis treatments, the importance of innovative platforms and technologies, particularly apps, continues to grow. Startups and investors in the cannabis sector have a unique opportunity to capitalize on